Capital Meets Care
The Power of Investor–Founder Partnerships in Asia Healthcare Innovation
Scaling a healthcare startup in Asia requires more than just capital—it requires a specialized ecosystem of trust and strategic alignment.
Join us for an evening dedicated to the art of the "Founder-Investor" partnership. We’re bringing together some of the most influential voices from Stanford Biodesign and the Global MedTech investment scene to discuss how cross-border collaborations are accelerating healthcare breakthroughs across Asia.
This isn't just a panel; it’s a high-level gathering for founders, investors, and clinical innovators to connect and exchange hard-earned insights.
💡Featured Speakers
Dr. Wayne Huang | Chief Central Superintendent of Show Chwan Healthcare System
Dr. Huang is a veteran surgeon and healthcare executive specializing in robotic surgery and medtech innovation. As the Dean of IRCAD Taiwan, he has established one of Asia’s premier surgical training centers. Beyond his clinical leadership, he serves as a General Partner at BE Health Ventures, bridging clinical practice with startup acceleration to drive the next generation of medical devices.
Dr. Fumiaki Ikeno | Program Director (U.S.) of Japan Biodesign at Stanford University
A renowned cardiologist and medtech innovator, Dr. Ikeno serves as the Program Director (U.S.) for Japan Biodesign at Stanford University. With over 20 years of experience in the U.S. and Japanese medical markets, he is a pivotal figure in cross-border healthcare innovation, advising numerous startups and serving as Chief Medical Officer for MedVenture Partners.
Vivian de Ruijter | Principal at Intuitive Ventures
A Stanford-trained physician and venture capitalist dedicated to the future of minimally invasive care. At Intuitive Ventures, she leads investments in digital health, focal therapeutics, and medical devices. Leveraging her surgical education background and investment expertise, she serves as a board observer for several high-growth medtech startups, including MedCrypt and Flywheel.
Jennifer Shen | Scientific Advisor at ICON pic
Jennifer is a physician-scientist and biotech investor with a deep background in gene therapy and clinical research from Stanford University School of Medicine. Formerly a Corporate Venture Director at AstraZeneca managing a $2B portfolio, she now provides strategic guidance for biotech startups on valuation, fundraising, and pipeline development, specializing in connecting Asian innovations with global capital.
Benjamin Chen | Partner at Panacea Venture
Benjamin is a principle-driven life science entrepreneur and investor with over 30 years of experience in biotechnology and diagnostics. Holding a PhD in Immunology and Cancer Biology, he has held senior R&D and executive roles at global giants like Roche and SyStemix. Currently, as a Partner at Panacea Venture, he focuses on identifying and scaling transformative healthcare technologies globally.
📅 Agenda
18:30 - 19:00 | Reception
19:00 - 19:10 | Opening Remarks
Arthur Chen/ Managing Partner, BE Health
SIT Representative
19:10 - 19:20 | Organizor Introduction
BE Health & SIT
19:20 - 20:00 | Fireside Chat
Moderator: Dr. Wayne Huang｜Dean, IRCAD Taiwan
Panelists:
Vivian de Ruijter | Stanford Byers Center for Biodesign
Fumiaki Ikeno | Stanford University / MedTech Veteran
Jennifer Shen | Healthcare VC & Strategy Expert
Benjamin Chen | Experienced Healthcare Entrepreneur & Executive
20:00 - 21:00 | Networking
Who Should Attend?
Founders: Navigating the journey from Seed to Series B in the healthcare space.
Investors: Looking for high-conviction MedTech and HealthTech opportunities in Asia.
Clinicians & Researchers: Interested in the commercialization of medical intellectual property.
📩 Registration
Space is strictly limited to ensure meaningful interactions. Please RSVP to secure your place among industry peers.